Flowing time on the peritoneal membrane

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 26-29

  Buemi, Michele ^a   Aloisi, Carmela ^a   Cutroneo, Giuseppa ^b   Nostro, Lorena ^a   Favaloro, Alessandro ^b  

^a Department of Internal Medicine ^*  (Italy)

^b Institute of Veterinary Anatomy   (Italy)

Author keywords

Ageing; Biocompatibility; Peritoneal dialysis; Ultrafiltration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINO ACID; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANTIFIBROTIC AGENT; AQUAPORIN; ARGININE DERIVATIVE; COLLAGEN TYPE 4; CYTOKINE; FIBRINOLYTIC AGENT; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; GLYCEROL; ICODEXTRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

BLOOD VESSEL INJURY; CAPILLARY WALL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETIC MICROANGIOPATHY; EDITORIAL; EXTRACELLULAR MATRIX; FLOW KINETICS; HUMAN; KIDNEY FAILURE; MESOTHELIUM CELL; NONHUMAN; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; TIME; ULTRAFILTRATION; UREMIA; VASCULAR DISEASE; VASCULARIZATION;

ADULT; CHILD; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEUM; ULTRAFILTRATION;

EID: 0347286852     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg446     Document Type: Editorial

References (20)

1. Bouts AHM, Davin JC, Groothoff JW, Ploos Van Amstel S, Zweers MM, Krediet R. Standard peritoneal permeability analysis in children. J Am Soc Nephrol 2000; 11: 943-950
2. Heimberger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B. Peritoneal fluid transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: 495-506
3. Fubholler A, Zur Nieden S, Grabensee B, Plum J. Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 2002; 13: 1055-1060
4. Heimburger O, Wang T, Lindholm B. Alterations in water and solute transport with time on peritoneal dialysis. Perit Dial Int 1999; 19: 83-90
5. Monquil M, Imholz A, Struijk D, Krediet R. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit Dial Int 1995; 15: 42-48
6. Stoenoiu MS, Ni J, Verkaeren C et al. Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum. J Am Soc Nephrol 2003; 14: 555-565
7. Struijk DG, Krediet RT, Koomen ST, Boeschoten EW, Hoek FJ, Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45: 1739-1744
8. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14-27
9. Yanez-Mo M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transitino of mesothelial cells. N Engl J Med 2003; 348: 403-413
10. Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA 1994; 91: 4130-4134
11. Shostak A, Wajsbrot E, Gotloib L. High glucose accelerates the life cycle of the in vivo exposed mesothelium. Kidney Int 2000; 58: 2044-2052
12. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999; 55: 341-356
13. Combet S, Ferrier ML, Van Landschoot M et al. Chronic uraemia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 2001; 12: 2146-2157
14. Krediet RT. The physiology of peritoneal solute transport and ultrafiltration. In: Gokal R, Khanna R, Krediet RT, Nolph KD, eds. The Texbook of Peritoneal Dialysis, 2nd Edn. Kluwer Academic Publishers, Dordrecht, The Netherlands, 2000; 135-172
15. Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000; 11: 717-728
16. Dobbie JW, Lloyd JK, Gall CA. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uraemia and CAPD patients. Adv Perit Dial 1990; 6: 3-12
17. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
18. Miyata T, Devuyst O, Kurokawa K, van Ypersele de Strihou C. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002; 61: 375-386
19. Devuyst O. New insights in the molecular mechanisms regulating peritoneal permeability. Nephrol Dial Transplant 2002; 17: 548-551
20. Hoff CM, Shockley TR. Peritoneal dialysis in the 21st century: the potential of gene therapy. J Am Soc Nephrol 2002; 13: S117-124